NO20063576L - 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes - Google Patents
1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetesInfo
- Publication number
- NO20063576L NO20063576L NO20063576A NO20063576A NO20063576L NO 20063576 L NO20063576 L NO 20063576L NO 20063576 A NO20063576 A NO 20063576A NO 20063576 A NO20063576 A NO 20063576A NO 20063576 L NO20063576 L NO 20063576L
- Authority
- NO
- Norway
- Prior art keywords
- obesity
- diabetes
- treatment
- analogous compounds
- dioxane derivatives
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 150000000093 1,3-dioxanes Chemical class 0.000 title 1
- 208000008589 Obesity Diseases 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 abstract 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN23MU2004 | 2004-01-09 | ||
| PCT/IN2005/000011 WO2005077943A1 (en) | 2004-01-09 | 2005-01-07 | 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063576L true NO20063576L (no) | 2006-10-06 |
Family
ID=34856875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063576A NO20063576L (no) | 2004-01-09 | 2006-08-07 | 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070105847A1 (pt) |
| EP (1) | EP1709035A1 (pt) |
| JP (1) | JP2007517862A (pt) |
| CN (1) | CN1930152A (pt) |
| AP (1) | AP2006003688A0 (pt) |
| AU (1) | AU2005213545B2 (pt) |
| BR (1) | BRPI0506477A (pt) |
| CA (1) | CA2555817A1 (pt) |
| EA (1) | EA200601295A1 (pt) |
| IL (1) | IL176758A0 (pt) |
| NO (1) | NO20063576L (pt) |
| OA (1) | OA13359A (pt) |
| WO (1) | WO2005077943A1 (pt) |
| ZA (1) | ZA200605731B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007096261A2 (en) * | 2006-02-21 | 2007-08-30 | F. Hoffmann-La Roche Ag | Process for the preparation of dioxane derivatives |
| CA2633440C (en) * | 2006-02-27 | 2011-06-21 | Cadila Healthcare Limited | 1,3-dioxane carboxylic acids |
| EP2150111B1 (en) | 2007-01-18 | 2016-10-19 | Evolva SA | Substituted 1,3-dioxanes useful as ppar modulators |
| MX2009007667A (es) | 2007-01-18 | 2011-12-08 | Evolva Sa | Profarmacos de 1,3-dioxanos sustituidos y sus usos. |
| AR085872A1 (es) | 2011-04-08 | 2013-10-30 | Basf Se | Derivados heterobiciclicos n-sustituidos utiles para combatir parasitos en plantas y/o animales, composiciones que los contienen y metodos para combatir dichas plagas |
| IN2014CN00712A (pt) | 2011-07-15 | 2015-04-03 | Basf Se | |
| IN2014CN01136A (pt) | 2011-08-12 | 2015-04-10 | Basf Se | |
| WO2013079601A1 (en) | 2011-12-02 | 2013-06-06 | Basf Se | Method and system for monitoring crops and/or infestation of crops with harmful organismus during storage |
| WO2013079600A1 (en) | 2011-12-02 | 2013-06-06 | Basf Se | Method and system for monitoring crops during storage |
| WO2013092868A1 (en) | 2011-12-21 | 2013-06-27 | Basf Se | N-thio-anthranilamide compounds and their use as pesticides |
| US9732051B2 (en) | 2011-12-23 | 2017-08-15 | Basf Se | Isothiazoline compounds for combating invertebrate pests |
| WO2013113789A1 (en) | 2012-02-02 | 2013-08-08 | Basf Se | N-thio-anthranilamide compounds and their use as pesticides |
| WO2013144228A1 (en) | 2012-03-29 | 2013-10-03 | Basf Se | Pesticidal methods using heterocyclic compounds and derivatives for combating animal pests |
| BR112014027133A2 (pt) | 2012-05-09 | 2017-06-27 | Basf Se | compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal. |
| KR20150100808A (ko) | 2012-12-21 | 2015-09-02 | 바스프 에스이 | 무척추동물 해충의 방제를 위한 시클로클라빈 및 이의 유도체 |
| WO2014128136A1 (en) | 2013-02-20 | 2014-08-28 | Basf Se | Anthranilamide compounds and their use as pesticides |
| CN112370455A (zh) * | 2020-10-19 | 2021-02-19 | 济南大学 | 一种磺酰胺衍生物作为α-葡萄糖苷酶抑制剂及其应用 |
| CN114315802B (zh) * | 2021-12-14 | 2023-06-16 | 西安医学院 | 一种喹唑啉含氮杂环衍生物及制备方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2781222A1 (fr) * | 1998-07-17 | 2000-01-21 | Lipha | Composes cycliques utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procede de preparation |
| IL152979A0 (en) * | 2000-05-26 | 2003-06-24 | Nippon Shinyaku Co Ltd | Heterocyclic compounds |
-
2005
- 2005-01-07 EP EP05726428A patent/EP1709035A1/en not_active Withdrawn
- 2005-01-07 EA EA200601295A patent/EA200601295A1/ru unknown
- 2005-01-07 CA CA002555817A patent/CA2555817A1/en not_active Abandoned
- 2005-01-07 CN CNA2005800071504A patent/CN1930152A/zh active Pending
- 2005-01-07 AU AU2005213545A patent/AU2005213545B2/en not_active Ceased
- 2005-01-07 WO PCT/IN2005/000011 patent/WO2005077943A1/en not_active Ceased
- 2005-01-07 BR BRPI0506477-5A patent/BRPI0506477A/pt not_active IP Right Cessation
- 2005-01-07 US US10/585,422 patent/US20070105847A1/en not_active Abandoned
- 2005-01-07 OA OA1200600225A patent/OA13359A/en unknown
- 2005-01-07 JP JP2006548588A patent/JP2007517862A/ja not_active Withdrawn
- 2005-01-07 AP AP2006003688A patent/AP2006003688A0/xx unknown
-
2006
- 2006-07-09 IL IL176758A patent/IL176758A0/en unknown
- 2006-07-10 ZA ZA200605731A patent/ZA200605731B/en unknown
- 2006-08-07 NO NO20063576A patent/NO20063576L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| OA13359A (en) | 2007-04-13 |
| CN1930152A (zh) | 2007-03-14 |
| AU2005213545A1 (en) | 2005-08-25 |
| BRPI0506477A (pt) | 2007-02-06 |
| ZA200605731B (en) | 2007-11-28 |
| US20070105847A1 (en) | 2007-05-10 |
| WO2005077943A1 (en) | 2005-08-25 |
| CA2555817A1 (en) | 2005-08-25 |
| EA200601295A1 (ru) | 2006-12-29 |
| JP2007517862A (ja) | 2007-07-05 |
| AP2006003688A0 (en) | 2006-08-31 |
| EP1709035A1 (en) | 2006-10-11 |
| AU2005213545B2 (en) | 2008-06-26 |
| IL176758A0 (en) | 2006-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20066055L (no) | Pyridinderivater | |
| NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
| NO20070855L (no) | Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer. | |
| NO20055516L (no) | Kannabinoidreceptorligander og anvendelser derav | |
| NO20064288L (no) | Tetraazabenzo(E)azulen-derivater og angaloger derav | |
| EA200600203A1 (ru) | Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2 | |
| NO20044534L (no) | Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer | |
| NO20054852L (no) | GFAT inhibitorer | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20092033L (no) | Nye forbindelser | |
| ATE407938T1 (de) | Glucopyranosyl-substituierte benzen-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür | |
| NO20084912L (no) | Bisykliske derivater som CETP-inhibitorer | |
| DE602005017895D1 (de) | Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren | |
| NO20081217L (no) | Nye benzotiazolonderivater | |
| NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
| NO20044763L (no) | 1-(aminoalkyl)-3-sulfonylazaindoler som 5-hydroksytryptamin-6 ligander | |
| EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
| NO20062357L (no) | Indolinderivater og anvendelse av dem ved behandling av sykdomstilstander som cancer | |
| NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
| NO20070570L (no) | Forbindelser. | |
| NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
| NO20090282L (no) | Syklopropylaminderivater som histamin H3 reseptormodulatorer | |
| NO20082214L (no) | 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer | |
| NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
| NO20065733L (no) | Naftalinderivater nyttige som histamin-3-reseptor ligander |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |